Ultralife Corporation — Q1 2024 Form 10-Q
Period: Three months ended March 31, 2024; comparative period ended March 31, 2023. Financial amounts are in millions of dollars unless stated otherwise. Ultralife designs and manufactures battery, power, communications, and electronics products for commercial, government, and defense customers through its Battery & Energy Products and Communications Systems segments.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Revenue | $41.927 | $31.916 |
| Gross profit / margin | $11.470 / 27.4% | $7.436 / 23.3% |
| Operating income / margin | $4.063 / 9.7% | $0.026 / 0.1% |
| Net income (loss) attributable to Ultralife | $2.891; $0.18 per diluted share | $(0.346); $(0.02) per diluted share |
| Adjusted EBITDA (non-GAAP) | $5.243; 12.5% of revenue | $1.155; 3.6% of revenue |
| Operating cash flow | $(0.081) | $(1.365) |
Revenue grew 31.4%. Battery & Energy Products revenue rose 22.9% to $34.989 million; Communications Systems revenue increased 101.3% to $6.938 million. Government/defense sales increased 83.4% and commercial sales increased 8.6%. Operating expenses were nearly flat at $7.407 million, while expenses fell to 17.7% of revenue from 23.2%. Interest and financing expense rose to $0.520 million from $0.424 million.
Cash used in operations reflected working-capital investment, especially $3.562 million in receivables and $1.699 million in inventory. Capital expenditures were $0.372 million. Financing activities provided $0.185 million, including $0.685 million from stock-option exercises and $0.500 million of term-loan repayments.
Financial position and liquidity
At March 31, 2024, cash was $10.099 million, current assets were $94.302 million, and current liabilities were $23.376 million. Total assets were $180.551 million and stockholders’ equity was $128.945 million. Debt principal comprised $19.580 million outstanding on the revolving facility and $5.667 million on the term loan; the balance sheet reports $25.140 million of debt net of unamortized issuance costs. The company was in compliance with its debt covenants. The revolver is a $30 million facility, subject to borrowing-base limits, and matures May 30, 2025; the term loan matures January 1, 2027.
Changes, outlook, and risks
- Gross margin improved 410 basis points, which management attributed to higher factory volume, favorable product mix, more evenly level-loaded production, and improved price realization.
- Management said Q1 2023 comparisons were affected by a ransomware attack that disrupted ordering, shipping, services, and planning. No ransom was paid; the cybersecurity insurance claim remains under review by the insurer.
- Management cited a healthy backlog and new product commercialization, and said it expects positive operating cash flow and available revolver borrowings to meet funding needs for the foreseeable future. It expressed optimism about profitable growth, debt reduction, strategic capital investment, and potential accretive acquisitions. No quantified earnings or revenue guidance was provided.
- Risks identified include customer concentration, changes or delays in military spending, supply-chain and raw-material disruptions, demand variability, rising interest costs on variable-rate debt, cybersecurity and IT disruption, foreign-exchange movements, product warranty and safety exposure, and regulatory or government-contracting matters.
- Commitments included approximately $0.330 million for production machinery and equipment. The company reported routine legal matters without awareness of a matter expected to have a material adverse effect, while noting that legal outcomes remain uncertain.
- The Q1 2024 tax provision was $0.703 million, including $0.650 million of deferred tax expense that management expects to be offset by U.S. net operating losses and tax credits for the foreseeable future. Management considers domestic NOLs and credits more likely than not to be utilized; certain U.K. NOLs remain subject to a valuation allowance and potential utilization limits.
Important facts for investors to verify
- Whether the sharp year-over-year revenue and margin gains are sustained, including the timing and concentration of government/defense programs and major customer shipments.
- How quickly working-capital investment converts to cash, given negative Q1 operating cash flow and higher receivables and inventory.
- Revolver availability under borrowing-base limits, refinancing or repayment plans before its May 2025 maturity, and continued covenant compliance.
- The outcome of the cybersecurity insurance claim and any continuing operational or financial effects from the 2023 attack.
- Whether management’s positive operating cash-flow outlook and backlog expectations are realized; adjusted EBITDA is a non-GAAP measure and does not reflect working-capital needs, capital spending, debt service, or taxes.